COVID-19 and Effect on Liver Transplant
| Autor: | Elizabeth C. Verna, Yael R. Nobel, Meaghan Phipps |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Liver transplantation Cirrhosis Coronavirus disease 2019 (COVID-19) SARS-CoV-2 business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) medicine.medical_treatment Chronic liver disease Gastroenterology COVID-19 medicine.disease Solid organ transplant Vaccination Liver disease Internal medicine Pandemic medicine business Liver (J Bajaj Section Editor) |
| Zdroj: | Current Treatment Options in Gastroenterology |
| ISSN: | 1534-309X 1092-8472 |
| DOI: | 10.1007/s11938-021-00355-w |
| Popis: | Purpose of review The Coronavirus disease-2019 (COVID-19) pandemic has significantly impacted all aspects of liver transplantation. We reviewed the literature regarding COVID-19 clinical outcomes, treatment, and vaccination of liver transplant candidates and recipients. Recent findings Patients with chronic liver disease, especially with cirrhosis, have higher morbidity and mortality from COVID-19 than patients without liver disease. Increased mortality has not been consistently seen in liver transplant recipients, in whom severe disease is more strongly associated advanced age and medical comorbidities, rather than with transplant-specific factors. While several targeted COVID-19 therapies have reported hepatotoxicity, these therapies may be safe and effective in patients with liver disease and liver transplant recipients. Questions remain regarding whether SARS-CoV-2 can be transmitted via the donor liver and whether transplant is safe in patients and/or donors with recent or active COVID-19. Summary COVID-19 has significantly affected the care of liver transplant candidates and recipients. Guidelines for the safe practice of liver transplantation are rapidly evolving, and current recommendations are discussed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink